However, there is a growing number of drugs, such as sodium-glucose cotransporter 2 (SGLT2) inhibitors [12] and long-acting insulin [13], that are less likely to cause hypoglycemia when used alone, and the primary treatment strategy is to prevent hypoglycemia [6, 7]. This evidence concerns the gene SLC5A2 and Hypoglycemia.